Skip to Navigation

Amitava Chattopadhyay


Amitava Chattopadhyay
Emerging Market Multinationals - Amitava Chattopadhyay


Ranbaxy Laboratories Limited: At the Crossroads

Ranbaxy Laboratories Limited: At the Crossroads

 

 

The case describes the challenges facing Ranbaxy, the third largest pharmaceutical company in India, which has set itself the goal of moving from the branded generic space to the greater value added branded pharmaceutical space. It has developed a one-a-day delivery system for ciprofloxacin a widely used antibiotic that is about to go off patent. Having sold the rights for the drug delivery system for markets outside India and the CIS to Bayer, the inventor of ciprofloxacin, Ranbaxy is wondering how it should market this new formulation in the India market in particular.


Teaching Objectives

The case poses several interesting questions. First, how should the one-a-day formulation of ciprofloxacin, to be called Cifran OD in India, be positioned? Ranbaxy currently markets ciprofloxacin under the name of Cifran as a branded generic in India. Should Cifran be discontinued when Cifran OD is launched? How should the Cifran OD positioning be implemented? Should the OD formulation be marketed by Ranbaxy alone or should it be co-marketed in collaboration with other local and global pharmaceutical players? The latter question facilitates an interesting discussion of when and how should one collaborate with competitors.

The case has been used for both MBA and executive audiences. It can be used in an introductory marketing course to highlight the power of good positioning. It can also be used in a course on pharmaceutical marketing or a course on how companies from emerging markets can climb the value added business ladder.



Download PDF


 

  Nov 1, 2003 | Cases




Download PDF



SHARE


 


Recent Tweets



Sat, 25 Jun @ 08:43 am

It's so sad. America one step closer to a Christian fundamental state. That is a frightening thought. https://t.co/dBAhL9NeGX

via Twitter for Android
Sat, 25 Jun @ 08:41 am

Welcome to @IndiGo6E. All kinds of checks in system to force you to pay more! It's legal but consumer perception of… https://t.co/MHvnIC6ECl

via Twitter for Android
Sat, 25 Jun @ 08:38 am

RT @rchowdhri: I understand that cos need to be profitable, but not with unreasonable customer experience. @IndiGo6E will not allow you me…

via Twitter for Android
Sat, 25 Jun @ 08:17 am

Totally agree. This ruling simply makes it worse for poor women and families. #FundamentalismRising in @USA https://t.co/qaREOCGvIN

via Twitter for Android
Sat, 25 Jun @ 08:15 am

Holland Village branch. This wait is quite normal. The coupon really annoyed me. It's disrespectful. So rubbing sal… https://t.co/9V1AjizYdq

via Twitter for Android
Thu, 23 Jun @ 06:43 am

After waiting an hour for service at @dbsbank I was offered a $5 coupon, redeemable at Sheng Siong supermarket, to… https://t.co/jAfKVsmUzO

via Twitter for Android

  Close About Papers Cases Books Teaching Musings Media Gallery Ask Amitava